September 2, 2020
At JacobsWyper Architects we have always been deeply entrenched in the world of Science & Technology, and we have been lucky to stay busy and actively involved with these clients during the pandemic. Our Life Science clients have proven to be absolutely critical to our country’s health and the economy when it seems everything else around us has ground to a halt.
At this point we have all read articles that point to the coming trend of companies reducing their real estate footprint after realizing that at least part of their workforce can work remotely. However, remote work is not feasible for much of the science community. Wet labs and cGMP spaces cannot (and should not) be replicated at home. Does this mean that we can expect to see a boon in real estate development that will see office buildings attempt to pivot into life science facilities?